BABA vs NTRP

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

NTRP exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company shows explosive year-over-year revenue growth of 1508%, this has failed to translate into profitability, as evidenced by a catastrophic operating margin of -257.04% and an ROE of -680.93%. Liquidity is a primary concern with a current ratio of 0.85 and a quick ratio of 0.55, suggesting the company may struggle to meet short-term obligations. The stock is fundamentally overvalued on a Price/Sales basis (19.00x) despite a long-term price collapse of 95.1% over five years.